Autologous blood/marrow transplantation - Autologous stem cell transplantation for malignant lymphomas

Authors
Remenyi, P Masszi, T Krivan, G Goda, V Reti, M
Citation
P. Remenyi et al., Autologous blood/marrow transplantation - Autologous stem cell transplantation for malignant lymphomas, BONE MAR TR, 22, 1998, pp. S104-S106
Citations number
4
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Journal title
BONE MARROW TRANSPLANTATION
ISSN journal
02683369 → ACNP
Volume
22
Year of publication
1998
Supplement
4
Pages
S104 - S106
Database
ISI
SICI code
0268-3369(199812)22:<S104:ABT-AS>2.0.ZU;2-U
Abstract
From December 1995 to April 1998, 20 consecutive adult patients suffering f rom chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin , 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation, Th e median follow up period is 15 months (range 6-28), The overall survival i s 18/20 (90 %), the event free survival is 13/20 (65%), None of the patient s died of transplant related cause.